Abstract
Branched-chain organic acidurias or organic acidaemias are a group of disorders that result from an abnormality of specific enzymes involving the catabolism of branched-chain amino acids (BCAAs). Collectively, the most commonly encountered are maple syrup urine disease (MSUD), isovaleric aciduria (IVA), propionic aciduria (PA) and methyl malonic aciduria (MMA). They can present clinically as a severe neonatal-onset form of metabolic distress, an acute and intermittent late-onset form, or a chronic progressive form presenting as hypotonia, failure to thrive, and developmental delay. Other rare disorders involving leucine, isoleucine, and valine catabolism are 3-methylcrotonyl glycinuria, 3-methylglutaconic (3-MGC) aciduria, short-/branched-chain acyl-CoA dehydrogenase deficiency, 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, isobutyryl-CoA dehydrogenase deficiency, 3-hydroxyisobutyric aciduria, and malonic aciduria.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Newborn Screening
- Maple Syrup Urine Disease
- Methylmalonic Acid
- Maple Syrup Urine Disease
- Metabolic Decompensation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Gascon GC, Ozand PT, Brismar J (1994) Movement disorders in childhood organic acidurias clinical, neuroimaging, and biochemical correlations. Brain Dev 16:94–103
Fariello G, Dionisi-Vici C, Orazi C et al. (1996) Cranial ultrasonography in maple syrup urine disease. AJNR Am J Neuroradiol 17:311–315
Morton DH, Strauss KA, Robinson DL et al. (2002) Diagnosis and treatment of maple syrup urine disease: a study of 36 patients. Pediatrics 109:999–1008
Treacy E, Clow CL, Reade TR et al. (1992) Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121–135
Schoenberger S, Schweiger B, Schwahn B et al. (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75
Kleopa KA, Raizen DM, Friedrich CA, Brown MJ, Bird SJ (2001) Acute axonal neuropathy in maple syrup urine disease. Muscle Nerve 24:284–287
Brismar J, Ozand PT (1994) CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR Am J Neuroradiol 15:1459–1473
Chemelli AP, Schocke M, Sperl W et al. (2000) Magnetic resonance spectroscopy (MRS) in five patients with treated propionic acidemia. J Magn Reson Imaging 11:596–600
Williams ZR, Hurley PE, Altiparmark UE et al. (2009) Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol 147: 929–933
Hörster F, Garbade SF, Zwickler T et al. (2009) Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis 32:630–639
Rutledge SL, Geraghty M, Mroczek E et al. (1993) Tubulointerstitial nephritis in methylmalonic acidemia. Pediatr Nephrol 7:81–82
Leonard JV (1995) The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 18:430–434
Lane TN, Spraker MK, Parker SS (2007) Propionic acidemia manifesting with low isoleucine generalized exfoliative dermatosis. Pediatr Dermatol 24:508–510
Gilmore A, Bock H-G, Nowicki M (2008) Hyperamylasemia/hyperlipasemia in a child with propionic acidemia. Am J Med Genet A 146A: 3090–3091
Romano S, Valayannopoulos V, Touati G et al. (2010) Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 156:128–134
Baumgartner D, Schöll-Burgi S, Sass JO et al. (2007) Prolonged QTc intervals and decreased left ventricular contractility in patients with propionic acidemia. J Pediatr 150: 192–197
Sato S, Kasahara M, Fukuda A et al. (2009) Liver transplantation in a patient with propionic acidemia requiring extracorporeal membrane oxygenation during severe metabolic decompensation. Pediatr Transplant 13:790–793
Morath MA, Okun JG, Müller IB et al. (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria a pathophysiological approach. J Inherit Metab Dis 31:35–43
Sbai D, Narcy C, Thompson GN et al. (1994) Contribution of oddchain fatty acid oxidation to propionate production in disorders of propionate metabolism. Am J Nutr 59:1332–1337
Leonard JV (1996) Stable isotope studies in propionic and methylmalonic acidaemia. Eur J Pediatr 156 [Suppl 1]:S67-S69
Aevarsson A, Chuang JL, Wynn RM et al. (2000) Crystal structure of human branched-chain α-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure 8:277–291
Ensenauer R, Vockley J, Willard JM et al. ( 2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75:1136–1142
Perez-Cerda C, Clavero S, Perez B et al. (2003) Functional analysis of PCCB mutations causing propionic acidemia based on expression studies in deficient human skin fibroblasts. Biochim Biophys Acta 1638:43–49
Perez B, Desviat LR, Rodriguez-Pombo P et al. (2003) Propionic acidemia: identification of twenty–four novel mutations in Europe and North America. Mol Genet Metab 78:59–67
Yorifuji T, Kawai M, Muroi J et al. (2002) Unexpectedly high prevalence of the mild form of propionic acidemia in Japan: presence of a common mutation and possible clinical implications. Hum Genet 111:161–165
Acquaviva C, Benoist JF, Pereira S et al. (2005) Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut (0) and mut (-) forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene. Hum Mutat 25:167–176
Lemer-Ellis JP, Dobson CM, Wai T et al. (2004) Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism. Hum Mutat 24:509–516
Jorge-Finnigan A, Aguado C, Sanchez-Alcudia R et al. (2010) Functional and structural analysis of five mutations identified in methylmalonic acidurie cblB type. Hum Mutat 31:1–10
Martínez MA, Rincón A, Desviat LR, Merinero B, Ugarte M, Pérez B (2005) Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants. Mol Genet Metab 84:317–325
Elpeleg O, Miller C, Hershkovitz E et al. (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081–1086
Carrozzo R, Dionisi-Vici C, Steuerwald U et al. (2007) SUCLA2 Mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130:862–874
Ostergaard E, Hansen FJ, Sorensen N, et al. (2007) Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 130:853–861
Ostergaard E, Christensen E, Kristensen E et al. (2007) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383–387
Ostergaard E, Schwartz M, Batbayli M et al. (2010) A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr 169:201–205
Bikker H, Bakker HD, Abeling NG et al. (2006) A homozygous nonsense mutation in the methylmalonyl-CoA epimerase gene (MCEE) results in mild methylmalonic aciduria. Hum Mutat 27: 640–643
Dobson MC, Gradinger A, Longo N et al. (2006) Homozygous nonsense mutation in the MCEE gene and siRNA suppression of methylmalonyl-CoA epimerase expression: a novel cause of mild methylmalonic acidurie. Mol Genet Metab 88: 327–333
Filipowicz HR, Ernst SL, Ashurst CL, Pasquali M, Longo N (2006) Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab 88:123–130
Nissim I (1999) New aspects of glutamine/glutamate metabolism: the role of acute pH changes. Am J Physiol 277:F493–497
Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348:2304–2312
Schulze A, Lindner M, Kohlmüller D et al. (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406
Rinaldo P, Tortorelli S, Matern D (2004) Recent developments and new applications of tandem mass spectrometry in newborn screening. Curr Opin Pediatr 16:427–433
MacDonald A, Dixon M, White F (2008) Disorders of amino acid metabolism, organic acidemias and urea cycle defects. In: Shaw V, Lawson M (eds) Clinical paediatric dietetics, 3rd edn. Blackwell, Oxford, UK, chap 17
Touati G, Valayannopoulos V, Mention K et al. (2006) Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixtures. J Inherit Metab Dis 29:288–299
Puliyanda DP, Harmon WE, Peterschmitt MJ, Irons M, Somers MJ (2002) Utility of hemodialysis in maple syrup urine disease. Pediatr Nephrol 17:239–242)
Strauss KA, Wardley B, Robinson D et al. (2010) Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab 99: 333–345
Grünewald S, Hinrichs F, Wendel U (1998) Pregnancy in a woman with maple syrup urine disease. J Inher Metab Dis 21:89–94
Strauss KA, Mazariegos GV, Sindhi R et al. (2006) Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 6: 557–564
Khanna A, Hart M, Nyhan WL et al. (2006) Domino liver transplantation in maple syrup urine disease. Liver Transplant 12: 876–882
Hilliges C, Awiszus D, Wendel U (1993) Intellectual performance of children with maple urine disease. Eur J Pediatr 152:144–147
Hoffmann B, Helbling C, Schadewaldt P, Wendel U (2006) Impact of longitudinal plasma leucine levels in the intellectual outcome in patients with classic MSUD. Pediatr Res 59:17–20
Fries MH, Rinaldo P, Schmidt-Sommerfeld E et al. (1996) Isovaleric acidemia: response to a leucine load after three weeks of supplementation with glycine, l-carnitine, and combined glycine-carnitine therapy. J Pediatr 129:449–452
Vockley J, Ensenauer R (2006) Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet 142:95–103
Shih VE, Aubry RH, De Grande G et al. (1984) Maternal isovaleric acidemia. J Pediatr 105:77–78
Picca S, Dionisi-Vici C, Abeni D et al. (2001) Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16:862–867
Filippi L, Gozzimi E, Fiorini et al. (2010) N-Carbamoylglutamate in emergency management of hyperammonemia in neonatal onset propionic and methylmalonic aciduria. Neonatology 97: 286–290
Matern D, Seydewitz, HH, Lehnert W et al. (1996) Primary treatment of propionic acidemia complicated by acute thiamine deficiency. J Pediatr 129:758–760
Touati G, Ogier de Baulny H, Rabier D et al. (2003) Beneficial effects of growth hormone treatment in children with methylmalonic and propionic acidurias (abstract). J Inherit Metab Dis 26 [Suppl 2]:40
Baumgartner ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inherit Metab Dis 18:138–142
De Baulny HO, Benoist JF, Rigal O et al. (2005) Methylmalonic and propionic acidemias: management and outcome. J Inherit Metab Dis 28:415–423
Dionisi Vici C, Deodato F, Roschinger W et al. (2006) »Classical« organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29:383–389
Lubrano R, Eli M, Rossi M et al. (2007) Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at ten years and review of the literature. Pediatr Nephrol 22:1209–1214
Diss E, Iams J, Reed N et al. (1995) Meythylmalonic aciduria in pregnancy: a case report. Am J Obstet Gynecol 172:1057–1059
Deodato F, Rizzo C, Boenzi S et al. (2002) Successful pregnancy in a woman with mut- methylmalonic acidaemia. J Inherit Metab Dis 25:133–134
Kasahara M, Horikawa R, Tagawa M et al. (2006) Current role of liver transplantation for methylmalonic acidemai: a review of literature. Pediatr Transplant 10: 943–947
Barshes NR, Vanatta, Patel AJ et al. (2006) Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review. Pediatr Transplant 10: 773–78
Lubrano R, Elli M, Rossi M et al. (2007) Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature. Pediatr Nephrol 22:1209–1214
Stricki M, Suormala T, Fowler B, Valle D, Baumgartner MR (2009) Cryptic exon activation by disruption exon splice enhancer: novel mechanism causing 3-methylcrotonyl-CoA carboxylase deficiency. J Biol Chem 284: 28953–28957
Baumgartner MR, Dantas MF, Suormala T et al. (2004) Isolated 3-methylcrotonyl-CoA carboxylase deficiency: evidence for an allele-specific dominant negative effect and responsiveness to biotin therapy. Am J Hum Genet 75:790–800
Arnold GL, Koeberl DD, Matern D et al. (2008) A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. Mol Genet Metab 93:363–370
Wortmann SB, Kluijtmans LA, Engelke UF et al. (2010) The 3-methylglutaconic acidurias: what’s new ? J Inher Metab Dis Sep 30 (Epub ahead of print)
Ijlst L, Loupatty FJ, Ruiter JP et al. (2002) 3-Methylglutaconic aciduria type I is caused by mutations in AUH. Am J Hum Genet 71:1463–1466
Mack M, Schniegler-Mattox U, Peters V et al. (2006) Biochemical characterization of human 3-methylglutaconyl-CoA hydratase and its role in leucine metabolism. FEBS J 273:2012–2022
Gunay-Aygun M, Gahl WA, Anikster Y (updated 2009) 3-Methylglutaconic aciduria type III. In Pagon RA, Bird TC, Dolan CR, Stephens K (eds) GeneReviews [internet]. University of Washington, Seattle 1993–2006, 28 Jul
Wortmann SB, Rodenburg RJ, Jonckheere A et al. (2009) Biochemical and genetic analysis of 3-methylglutaconic acidurie type IV: a diagnostic strategy. Brain 132:136–146
Di Rosa G, Deodato F, Loupatty FJ et al. (2006) Hypertrophic cardiomyopathy, cataract, developmental delay, lactic acidosis: a novel subtype of 3-methylglutaconic aciduria. J Inherit Metab Dis 29:546–550
Houstek J, Kmoch S, Zeman J (2009) TMEM70-protein – a novel ancillary factor of mammalian ATP synthase. Biochim Biophys Acta 1787:529–532
Davey KM, Parboosingh JS, McLeod DR et al. (2006) Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J Med Genet 43:385–393
Sass JO, Ensenauer R, Röschinger W et al. (2008) 2-Methylbutyrylcoenzyme A dehydrogenase deficiency: functional and molecular studies on a defect in isoleucine catabolism. Mol Genet Metab 93:30–35
Garcia-Villoria J, Navarro-Sastre A, Fons C et al. (2009) Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis. Clin Biochem 42:27–33
Yang SY, He XY, Miller D (2007) HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids. Mol Genet Metab 92:36–42
Pedersen CB, Bischoff C, Christensen E et al. (2006) Variations in IBD (ACAD8) in children with elevated C4-acylcarnitine detected by tandem mass spectrometry newborn screening. Pediatr Res 60:315–320
Oglesbee D, He M, Majumber N et al. (2007) Development of a newborn screening follow-up algorithm for the diagnosis of isobutyryl-CoA dehydrogenase deficiency. Genet Med 9:108–116
Chambliss KL, Gray RG, Rylance G et al. (2000) Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. J Inherit Metab Dis 23 497–504
Brown GK, Huint SM, Scholem R et al. (1982) Hydroxyisobutyrylcoenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations. Pediatrics 70:532–538
Salomons GS, Jakobs C, Landegge Pope L et al. (2007) Clinical, enzymatic and molecular characterization of nine new patients with malonyl- coenzyme A decarboxylase deficiency. J Inherit Metab Dis 30: 23–28
Sloan JL, Johnston JJ, Manoli I et al. (2011) Exone sequencing identifies ACSF 3 as a cause of combined malonic and methymlonic aciduria. Nature Genetics 43: 883–886
Footitt EJ, Stafford J, Dixon M et al. (2010) Use of a long-chain triglyceride-restricted/medium-chain triglyceride-supplemented diet in a case of malonyl-CoA decarboxylase deficiency with cardiomyopathy. J Inherit Metab Dis DOI 10.1007/s10545-010-9137-z
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Baulny, H.O., Dionisi-Vici, C., Wendel, U. (2012). Branched-chain Organic Acidurias/Acidaemias. In: Saudubray, JM., van den Berghe, G., Walter, J.H. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15720-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-15720-2_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-15719-6
Online ISBN: 978-3-642-15720-2
eBook Packages: MedicineMedicine (R0)